Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hellmann

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Cancer|January 1, 1978
Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomasK Hellmann, R D Ryall, E Macdonald, et al.
Zoonoses and Public Health|May 21, 2008
Molecular evidence for Bartonella spp. in cat and dog fleas from Germany and FranceF T Just, J Gilles, I Pradel, et al.
The American Naturalist|August 2, 2023
Social Environment Influences the Temporal Dynamics of Sneak-Spawning in a Fish with Alternative Reproductive TacticsMatthew C Kustra, Kelly A Stiver, Susan Marsh-Rollo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tractB J Smith, M Evans, K Hellmann, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1973
Immunosuppression by the bisdioxopiperazines ICRF 154 and 159D I Duke, E O Field, M Finch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancerJ M Gilbert, K Hellmann, M Evans, et al.
Cancer|October 1, 1974
Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159R D Ryall, I W Hanham, K A Newton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
A controlled prospective trial of adjuvant razoxane in resectable colorectal cancerJ M Gilbert, P C Cassell, H Ellis, et al.
Cancer Treatment Reviews|March 1, 1991
Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reductionJ Koning, P Palmer, C R Franks, et al.
The British Journal of Surgery|June 1, 1986
Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-upJ M Gilbert, K Hellmann, M Evans, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Cancer|January 1, 1978
Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomasK Hellmann, R D Ryall, E Macdonald, et al.
Zoonoses and Public Health|May 21, 2008
Molecular evidence for Bartonella spp. in cat and dog fleas from Germany and FranceF T Just, J Gilles, I Pradel, et al.
The American Naturalist|August 2, 2023
Social Environment Influences the Temporal Dynamics of Sneak-Spawning in a Fish with Alternative Reproductive TacticsMatthew C Kustra, Kelly A Stiver, Susan Marsh-Rollo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tractB J Smith, M Evans, K Hellmann, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1973
Immunosuppression by the bisdioxopiperazines ICRF 154 and 159D I Duke, E O Field, M Finch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancerJ M Gilbert, K Hellmann, M Evans, et al.
Cancer|October 1, 1974
Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159R D Ryall, I W Hanham, K A Newton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
A controlled prospective trial of adjuvant razoxane in resectable colorectal cancerJ M Gilbert, P C Cassell, H Ellis, et al.
Cancer Treatment Reviews|March 1, 1991
Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reductionJ Koning, P Palmer, C R Franks, et al.
The British Journal of Surgery|June 1, 1986
Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-upJ M Gilbert, K Hellmann, M Evans, et al.
Pageof 12